Digital follow-up care for colorectal cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project is testing a new, digitally managed follow-up program for colorectal cancer survivors, specifically focusing on stage I and low-risk stage II patients. The program aims to address individual patient needs by monitoring not only for cancer recurrence but also for late adverse effects and psychological distress. It utilizes circulating tumor DNA (ctDNA) as a biomarker for recurrence monitoring and incorporates electronic patient-reported outcome measures (ePROMs) to systematically treat late effects. The goal is to enhance the quality of life for survivors by providing tailored support rather than a one-size-fits-all approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients treated for stage I and low risk stage II colorectal cancer with curative intend.
2. Age 18 years or older.
3. Understands spoken and written Danish language.
4. Able to use digital care-guide as smartphone application.
5. The patient is also included in DANISH.MRD part 1.

Exclusion Criteria:

1. Patients who are unlikely to comply with the protocol, unable to return for subsequent visits and/or otherwise considered by the PIs to be unlikely to complete the study.
2. Patients who are not able or willing to adhere to the digital platform.
3. Patients treated only with local endoscopic resection, e.g.,Transanal Endoscopic microsurgery (TEM).

Where it's running

• Gødstrup Hospital
  Herning, Central Jutland, Denmark Recruiting
• Regional Hospital Randers
  Randers, Central Jutland, Denmark Recruiting
• Aalborg University Hospital
  Aalborg, North Denmark, Denmark Recruiting
• Odense University Hospital
  Odense, The Region of Southern Denmark, Denmark Recruiting
• Svendborg Sygehus
  Svendborg, The Region of Southern Denmark, Denmark Recruiting
• Aarhus University Hospital
  Aarhus, Denmark Recruiting

Study contacts

• Principal investigator: Lene H Iversen, Prof. — University of Aarhus
• Study coordinator: Claus L Andersen, Prof.
• Email: cla@clin.au.dk
• Phone: +45 78455319

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exercise to improve outcomes in colorectal cancer patients

  This study is testing whether aerobic and resistance exercise can help people with metastatic colorectal cancer feel better and handle chemotherapy without needing to change their treatment.

  Recruiting at 13 sites Radboud University Medical Center · 's-Hertogenbosch and 12 other locations · NCT04754672

• Knife-assisted full-thickness resection for rectal lesions in a multicenter setting

  A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.

  Recruiting University Hospital, Ghent · Ghent · NCT07923682

• Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model

  This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.

  Recruiting Peking Union Medical College Hospital · Ningbo, Zhejiang · NCT07919418

• Integrated genomic and clinical database for cancer biomarker discovery

  Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.

  Recruiting Samsung Medical Center · Seoul, Gang-Nam · NCT07911267

• Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery

  Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.

  Recruiting Semmelweis University · Budapest · NCT07896174

• Liver transplantation for colorectal cancer with liver metastases

  This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.

  Recruiting Pontificia Universidad Catolica de Chile · Santiago, Santiago Metropolitan · NCT07884110

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.